Emerging markets where cold-chain infrastructure is limited stand to benefit most
Sanders et al
Thus, in perfect agreement with the recent ADA-EASD consensus report [6], we also encourage the adoption of GLP-1RA plus SGLT2i combination therapy in T2DM patients with established ASCVD (coronary artery disease, cerebrovascular disease, or peripheral arterial disease) or multiple risk factors for ASCVD (i.e., age 55 years, obesity, dyslipidemia, hypertension, current tobacco use, left ventricular hypertrophy, and/or proteinuria) whose HbA1c remains suboptimal despite initial treatment with only one of these agents
Supporting Healthier Eating Habits Wegovy Pill works best when you combine your medication with a disciplined diet plan and a healthy lifestyle
10.1016/j.exger.2024.112522 38 YingY.TangQ.YangJ.GuiS.ZhangY.ShenY.et al (2024)
Literature search on search engines revealed scarce results regarding this topic